ARIMIPLEX is indicated for adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.
ARIMIPLEX is indicated for the first-line treatment of postmenopausal women with hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer.
ARIMIPLEX is indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy .
Post Footer automatically generated by Add Post Footer Plugin for wordpress.